XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities of Continuing Operations    
Net income from continuing operations $ 11,508 $ 8,534
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities of continuing operations:    
Amortization 1,623 1,231
Depreciation 1,394 1,148
Intangible asset impairment charges 910 0
Loss (income) from investments in equity securities, net 1,361 (1,535)
Charge for the acquisition of Pandion Therapeutics, Inc. 0 1,556
Deferred income taxes (1,261) 28
Share-based compensation 396 360
Other 1,169 499
Net changes in assets and liabilities (2,435) (3,794)
Net Cash Provided by Operating Activities of Continuing Operations 14,665 8,027
Cash Flows from Investing Activities of Continuing Operations    
Capital expenditures (3,239) (3,240)
Purchases of securities and other investments (710) (1)
Proceeds from sales of securities and other investments 709 497
Acquisition of Pandion Therapeutics, Inc., net of cash acquired 0 (1,554)
Other acquisitions, net of cash acquired (121) (89)
Other 149 15
Net Cash Used in Investing Activities of Continuing Operations (3,212) (4,372)
Cash Flows from Financing Activities of Continuing Operations    
Net change in short-term borrowings 0 (3,983)
Payments on debt (2,250) (1,153)
Distribution from Organon & Co. 0 9,000
Purchases of treasury stock 0 (822)
Dividends paid to stockholders (5,262) (4,967)
Proceeds from exercise of stock options 119 68
Other (172) (253)
Net Cash Used in Financing Activities of Continuing Operations (7,565) (2,110)
Cash Flows from Discontinued Operations    
Net cash provided by operating activities 0 1,051
Net cash used in investing activities 0 (134)
Net cash used in financing activities 0 (504)
Net Cash Flows Provided by Discontinued Operations 0 413
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (776) (65)
Net Increase in Cash, Cash Equivalents and Restricted Cash 3,112 1,893
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $71 and $103 at January 1, 2022 and 2021, respectively, included in Other current assets) 8,167 8,153
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $134 and $30 at September 30, 2022 and 2021, respectively, included in Other current assets) $ 11,279 $ 10,046